OncoSec Medical (ONCSQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock ONCSQ vs. AMPE, EFTR, CLVR, HSTO, PXMD, ATNFW, LBPSW, AEHAW, AIMDW, and ALVOWShould you be buying OncoSec Medical stock or one of its competitors? The main competitors of OncoSec Medical include Ampio Pharmaceuticals (AMPE), eFFECTOR Therapeutics (EFTR), Clever Leaves (CLVR), Histogen (HSTO), PaxMedica (PXMD), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), and Alvotech (ALVOW). These companies are all part of the "pharmaceutical products" industry. OncoSec Medical vs. Its Competitors Ampio Pharmaceuticals eFFECTOR Therapeutics Clever Leaves Histogen PaxMedica 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Ampio Pharmaceuticals (NYSE:AMPE) and OncoSec Medical (NASDAQ:ONCSQ) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings and dividends. Does the media prefer AMPE or ONCSQ? In the previous week, Ampio Pharmaceuticals' average media sentiment score of 0.00 equaled OncoSec Medical'saverage media sentiment score. Company Overall Sentiment Ampio Pharmaceuticals Neutral OncoSec Medical Neutral Which has more risk and volatility, AMPE or ONCSQ? Ampio Pharmaceuticals has a beta of 4.76, indicating that its stock price is 376% more volatile than the S&P 500. Comparatively, OncoSec Medical has a beta of -19.7, indicating that its stock price is 2,070% less volatile than the S&P 500. Which has higher valuation & earnings, AMPE or ONCSQ? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmpio PharmaceuticalsN/AN/A-$8.63M-$11.010.00OncoSec MedicalN/AN/A-$34.18MN/AN/A Do institutionals & insiders believe in AMPE or ONCSQ? 5.7% of Ampio Pharmaceuticals shares are owned by institutional investors. 3.3% of Ampio Pharmaceuticals shares are owned by company insiders. Comparatively, 1.3% of OncoSec Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is AMPE or ONCSQ more profitable? Company Net Margins Return on Equity Return on Assets Ampio PharmaceuticalsN/A N/A N/A OncoSec Medical N/A N/A N/A SummaryAmpio Pharmaceuticals beats OncoSec Medical on 4 of the 4 factors compared between the two stocks. Get OncoSec Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCSQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ONCSQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONCSQ vs. The Competition Export to ExcelMetricOncoSec MedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$790.06M$5.46B$9.67BDividend YieldN/A4.84%3.99%4.14%P/E RatioN/A1.3129.9924.97Price / SalesN/A25.16375.5577.11Price / CashN/A19.5635.9458.58Price / BookN/A6.558.165.68Net Income-$34.18M-$4.07M$3.25B$265.38M OncoSec Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCSQOncoSec MedicalN/AN/AN/AN/A$1KN/A0.0040AMPEAmpio PharmaceuticalsN/A$0.00flatN/A+31.8%$3KN/A0.0020EFTReFFECTOR Therapeutics0.0857 of 5 stars$0.00+200.0%N/A-99.6%$3KN/A0.0010CLVRClever LeavesN/A$0.00flatN/AN/A$1K$17.42M0.00560HSTOHistogenN/A$0.00flatN/AN/A$1K$19K0.0020PXMDPaxMedicaN/AN/AN/A-99.9%$1KN/A0.002ATNFW180 Life SciencesN/A$0.01+26.0%N/A-7.4%$0.00N/A0.007High Trading VolumeLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.00flatN/A-75.6%$0.00N/A0.002Gap DownAIMDWAinosN/A$0.13+0.7%N/AN/A$0.00$106.21K0.0040Gap UpALVOWAlvotechN/A$1.94-27.1%N/A-52.1%$0.00$585.60M0.004Gap Down Related Companies and Tools Related Companies Ampio Pharmaceuticals Alternatives eFFECTOR Therapeutics Alternatives Clever Leaves Alternatives Histogen Alternatives PaxMedica Alternatives 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ONCSQ) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredGold Hit $3,500. Here’s What’s Next…Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldm...Reagan Gold Group | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoSec Medical Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share OncoSec Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
